Results 171 to 180 of about 4,610 (193)

Recent Recommendations on Bisphosphonate-Associated Osteonecrosis of the Jaw

Dental Update, 2008
There is increasing awareness of the importance of osteonecrosis of the jaw developing in patients taking bisphosphonates. A recent working party of the American Society for Bone and Mineral Research has developed recommendations on the prevention and treatment of this condition which dentists will find useful.
Yazdana, Arrain, Tahir, Masud
openaire   +2 more sources

Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis

Supportive Care in Cancer, 2006
Prevalence of bisphosphonate-associated osteonecrosis of the jaws within the catchment area of a university hospital maxillofacial unit and to review the outcome of treatment.In a retrospective study, all patients with osteonecrosis, osteomyelitis and osteoradionecrosis treated in the period from January 2000 to March 2005 in the department for Maxillo
Christian, Walter, Knut A, Grötz, Martin, Kunkel, Bilal, Al-Nawas   +3 more
openaire   +2 more sources

Oral bisphosphonate associated osteonecrosis of the jaws: three case reports

British Dental Journal, 2007
Bisphosphonate associated osteonecrosis of the jaws (BONJ) has been well documented recently in relation to intravenous preparations of the drug. These are most commonly used as part of the management of hypercalcaemia of malignancy and metastatic bone disease but BONJ can also occur in association with oral bisphosphonate use.
N J, Malden, A Y, Pai
openaire   +2 more sources

Bisphosphonate-associated osteonecrosis (BON) of the jaws: A possible treatment?

Journal of Oral and Maxillofacial Surgery, 2006
Management of bisphosphonate-associated osteonecrosis (BON) of the jaws is currently a very topical subject. At present, there is no effective treatment for this condition. Several authors have recommended that prevention, when possible, of BON in patients at risk is the gold standard.
VESCOVI, Paolo, MERIGO E, MELETI, Marco, MANFREDI, Maddalena   +3 more
openaire   +3 more sources

Incidence and risk factors of bisphosphonate‐associated osteonecrosis of the jaws

Head & Neck, 2007
AbstractBackgroundIntravenous bisphosphonate therapy has been used for treatment of benign and malignant bone diseases and has been linked to osteonecrosis of the jaws.MethodsRecords of 638 patients treated with intravenous bisphosphonates were reviewed.
Matthew R, Stumpe, Rakesh K, Chandra, Furhan, Yunus, Sandeep, Samant   +3 more
openaire   +2 more sources

[Bisphosphonate-associated osteonecrosis of the jaw].

Schmerz (Berlin, Germany), 2016
Bisphosphonates (BP) are used in the treatment of severe osteoporosis and metastasis of malignant diseases. A possible relationship between the occurrence of osteonecrosis of the jaw and BP therapy was first described in 2003. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is difficult to treat.
S, Koy, M, Schubert, J, Koy, M, Ney, G, Lauer, R, Sabatowski   +5 more
openaire   +1 more source

Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws

Dentomaxillofacial Radiology, 2006
It is important to recognize osteonecrosis of the jaws in patients treated with bisphosphonates because an early diagnosis can make a significant difference to the outcome of the disease. The aim of this study is to describe the radiological features of bisphosphonate osteonecrosis (BON) in order to aid its prompt recognition.A conventional radiograph,
CHIANDUSSI, SILVIA, BIASOTTO, MATTEO, DORE, FRANCA, CAVALLI, FABIO, COVA, MARIA ASSUNTA, DI LENARDA, Roberto   +5 more
openaire   +3 more sources

Dental Panoramic Radiographic Evaluation in Bisphosphonate-Associated Osteonecrosis of the Jaws

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2008
Objectives:  To determine the extent to which clinical and radiographic features of bisphosphonate‐associated osteonecrosis of the jaw (BONJ) are correlated.Design:  Retrospective case review.Methods:  The records of 39 patients diagnosed with BONJ and examined by panoramic radiography were retrospectively evaluated.
N, Treister, N, Sheehy, E H, Bae, B, Friedland, M, Lerman, S, Woo   +5 more
openaire   +2 more sources

Identification and Treatment of Bisphosphonate-Associated Actinomycotic Osteonecrosis of the Jaws

Implant Dentistry, 2011
Osteonecrosis of the jaws (ONJ) is a condition characterized by necrotic exposed bone in the jaws of patients receiving intravenous or oral bisphosphonate therapy. A review of the medical and dental literature reveals that the pathoetiology of ONJ remains unknown and there is no established link that bisphosphonates are the primary cause of this bone ...
Cameron Y S, Lee, Francis D, Pien, Jon B, Suzuki   +2 more
openaire   +2 more sources

Bisphosphonate-associated osteonecrosis of the jaws

Journal of Oral and Maxillofacial Surgery, 2005
MICHAEL R. MARKIEWICZ, JOSEPH E. MARGARONE, JOHN H. CAMPBELL, ALFREDO AGUIRRE   +3 more
openaire   +3 more sources